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Abstract
Few trials have evaluated the metabolic effects and health outcomes of lowering dietary n-6
PUFA. The objectives of the present paper were (1) to report the methods employed to lower
dietary n-6 PUFA, while either increasing or maintaining n-3 PUFA intake and (2) to validate our
methods with 24 h recalls and erythrocyte fatty acid analyses. A total of sixty-seven subjects were
randomised to either (1) an average-n-3 PUFA, low-n-6 PUFA (L6) intervention designed to
lower linoleic acid (LA; ≤2·5 % of energy (en%)) and arachidonic acid (≤60 mg/d), while
maintaining an average US intake of n-3 PUFA or (2) a high-n-3 PUFA, low-n-6 PUFA (H3-L6)
intervention designed to lower n-6 LA, while increasing the n-3 PUFA α-linolenic acid (ALA;
≥1·5 en%) and EPA + DHA (≥1000 mg/d). Pre- and intra-intervention nutrient intakes were
estimated with six 24 h dietary recalls per subject. Both groups achieved the targeted reductions in
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dietary LA to ≤2·5 en% (median LA 2·45 (2·1, 3·1); P<0·001). Intakes of n-3 PUFA did not
change for the L6 group. Target increases in n-3 ALA (median 1·6 en%, (1·3, 2·0), P<0·001) and
EPA + DHA (1482 mg, (374, 2558), P<0·001) were achieved in the H3-L6 group. Dietary
changes were validated by corresponding changes in erythrocyte n-6 and n-3 fatty acid
composition. Dietary LA can be lowered to ≤2·5 en%, with or without concurrent increases in
dietary n-3 PUFA, in an outpatient clinical trial setting using this integrated diet method.
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Modern per capita US n-6 linoleic acid (LA) intake of 6·3–6·7 % of energy (en%)(1) is
substantially higher than available data estimating historical US (2·2 en%)(2) and
evolutionary (2·3–3·6 en%) LA consumption(3). Since the early 1960s, dietary advice to
substitute vegetable oils for animal fats contributed to major changes in the US food supply,
including a reduction in SFA(1) and a 3-fold increase in LA intake(2). Data on the metabolic
and health effects of these marked dietary changes are limited(4). Dietary n-6 and n-3 PUFA
are known to alter the composition and metabolic functions of various tissues in both animal
models(5 – 8) and human subjects(4,9,10). Several, but not all, controlled trials comparing n-3
PUFA supplements v. placebo have demonstrated substantial health benefits(11 – 15).
Since n-6 and n-3 fatty acids compete to some extent for enzymatic conversion, tissue
incorporation and metabolism to bioactive derivatives, lowering dietary LA could
potentially augment the benefits of n-3 fatty acids or have substantial independent health
benefits(15 – 17). To our knowledge, no human trial has evaluated the long-term effects of
lowering dietary LA from modern intakes to amounts consistent with historical US or
evolutionary intakes for the prevention or management of any medical condition.
Challenges for evaluating the effects of dietary LA lowering in Western populations include:
(1) the ubiquity of LA in the food supply, with LA-rich oils added to most packaged food
items; (2) wide variability in the LA content of many similar food items; and (3) the
abundance of LA in adipose tissue stores of Western populations. Because LA has a slow
turnover rate (half-life 1–2 years) in adipose tissue(18,19), dietary changes may need to be
maintained for relatively long periods to achieve maximal alterations in tissue composition
and function.
With these unique challenges in mind, we developed a novel, integrated diet method
designed to achieve marked reductions in dietary LA in an outpatient setting. Subjects with
chronic daily headaches were randomised to one of two low-n-6 study diets: (1) an average-
n-3, low-n-6 (L6) diet and (2) a high-n-3, low-n-6 (H3-L6) diet. The interventions combined
four key elements: (1) provision of both unprepared and specially formulated prepared foods
accounting for two-thirds of total energy intake; (2) intensive dietitian-administered
counselling, with targeted and individually tailored aspects; (3) continuous self-monitoring;
and (4) access to an intervention-specific website to complement and reinforce dietitian
advice.
MacIntosh et al. Page 2






















This novel dietary method was developed to achieve: (1) a reduction in n-6 LA intake to
≤2·5 en% in both intervention groups; and (2) an increase in n-3 EPA + DHA to ≥1000 mg/d
in the H3-L6 group, with no change in the L6 group. These goals were evaluated by
administering six 24 h dietary recalls per subject. Erythrocyte fatty acids were analysed to
provide further evidence of adherence. Complete metabolic and clinical headache outcomes
will be presented in a separate paper.
Experimental methods
Participants
Individuals who were at least 18 years old and who satisfied the 2004 International
Classification of Headache Disorders criteria for chronic daily headaches(20) were invited to
participate. Patients with chronic daily headaches, defined as at least fifteen headache days
per month and 4 h/d(21), were recruited from the following sources: (1) specialty headache
clinics; (2) broadcast email to the University of North Carolina (UNC) community; and (3)
brochures placed in UNC medical clinics. This population with chronic and frequent pain
was selected in order to evaluate the hypothesis that targeted alterations in dietary fatty acids
can reduce the frequency and severity of pain outcomes. Pregnant women and those
regularly consuming fatty acid supplements were excluded. The present study was
conducted according to the Declaration of Helsinki guidelines, with all procedures involving
human subjects approved by the UNC-Chapel Hill Institutional Review Board. All
participants provided written informed consent. This trial is registered under
ClinicalTrials.gov (NCT01157208).
Development of study diets
Two research diets were developed for the 12-week, parallel-group randomised dietary
intervention. The L6 diet was designed to reduce LA and arachidonic acid (AA) to ≤2·5 en%
and 60 mg/d, respectively, while providing average US intakes of ALA and EPA + DHA.
The H3-L6 diet was designed to reduce LA to ≤2·5 en%, while increasing ALA and EPA +
DHA. Both diets were designed to provide typical US amounts of total protein, total
carbohydrate and total fat.
The average-n-3, low-n-6 diet
Lowering n-6 PUFA—LA (18 : 2n-6) is the predominant PUFA in US/Western diets(1).
High-LA oils (soyabean, maize, cottonseed, safflower and sunflower) are the predominant
fat sources in most US salad dressings, margarines, mayonnaises and cooking oils. LA-rich
oils are also added to most packaged food items, including breads, cereals, soups and tomato
sauce, as well as most snack foods such as cookies, chips (crisps) and crackers
(Supplementary Appendix 1, available online).
To achieve the intervention-specific LA intake targets, study foods were carefully selected
to replace those containing substantial quantities of LA (Supplementary Appendix 1,
available online). The United States Department of Agriculture National Nutrient Database
for Standard Reference, Release 21, was used to screen high-LA and low-LA foods for
potential inclusion and exclusion from research diets. Next, to verify low LA content, the
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fatty acid content of multiple brands of low-LA foods was analysed by GC, as previously
described(22). The lowest-LA foods were selected for inclusion in both diets. To facilitate
dietary LA lowering, participants were provided with, and instructed to exclusively use,
study-provided low-LA oils and fat sources (Table 1), including coconut oil, macadamia nut
oil, low-LA olive oil, butter, fat-free mayonnaise and macadamia-vinaigrette salad dressing.
Because most US packaged food items contain substantial amounts of added LA,
participants also received a variety of low-LA substitute foods, including crackers, tortillas,
breads and popcorn. Research foods were procured and prepared by the UNC Nutrition
Research and Metabolism Core of the Clinical and Translational Research Center.
Lowering dietary arachidonic acid—Foods with high AA (20 : 4n-6) content,
according to the United States Department of Agriculture National Nutrient Database for
Standard Reference, Release 21, were first identified as key items to eliminate from the
research diets (Supplementary Appendix 1, available online). Fatty acid analysis was then
performed on several animal protein sources in order to identify study foods containing the
lowest amounts of both LA and AA (Table 1). Participants were instructed to restrict
consumption of egg yolks, meat, most poultry and certain seafood. Adequate protein intake
was achieved with beans, very lean (low n-3) seafood, turkey, egg-whites and dairy
products. Examples of study-provided protein sources included canned beans, prepared
vegetarian chili, frozen low-fat seafood, cheeses and low-fat turkey (Table 1).
Average n-3 PUFA—The average US intake of ALA (18 : 3n-3) is about 0·6 en%(1),
mostly from soyabean and rapeseed oils. Because these vegetable oil sources of ALA were
restricted, a small amount of ground flaxseed (concentrated source of ALA) was added to L6
diet foods to maintain the average US ALA intake. Participants had the option of consuming
specially formulated muffins, granola or 3 g of ground flaxseed added to foods of their
choice. To achieve the average US EPA + DHA intake of 0·11 g/d, participants received
small amounts of seafood with the lowest amounts of EPA + DHA and AA (Table 1).
The high-n-3, low-n-6 diet
Lowering dietary linoleic acid—H3-L6 dieters were instructed to replace all high-LA
foods in their diet with the same study-provided oils, fats and other low-LA foods used in
the L6 diet (Table 1).
Increasing dietary n-3 PUFA—H3-L6 subjects were instructed to consume
approximately 1·5 en% as ALA (Table 2), mostly from ground flaxseed. Options included
14 g of ground flaxseed each day for addition to foods of their choice, or specially prepared
granola, muffins, granola bars and/or bean dip containing flaxseed. To meet EPA + DHA
intake targets, H3-L6 dieters were counselled to consume 113–230 g of fatty fish or shellfish
per d in place of other protein sources. Fatty acid analyses were performed on numerous
types and brands of seafood to ensure selection of those with the highest EPA + DHA and
low amounts of LA and AA (Table 1). The study-provided foods included frozen wild
salmon fillets, trout fillets, tuna steaks, canned high-n-3 albacore tuna, canned high-n-3 wild
salmon and sardines. The small amount of AA present in study-provided seafood resulted in
daily AA consumption comparable with typical US diets (Table 2).
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Dietitian counselling and provision of study foods—The dietitian met with each
study participant for 2 h at the initial visit to administer a diet assessment tool, provide
tailored dietary advice, review all diet education materials and provide a 2-week supply of
food. Participants attended six 45-min follow-up diet counselling sessions at 2-week
intervals throughout the 12-week intervention period. At each follow-up session,
participants selected a 2-week supply of prepared and unprepared study foods (sufficient for
approximately two-thirds of their energy needs) from a fixed food list (Table 1). Study foods
were prepared by the UNC Metabolic Kitchen and packed into 57 litre rolling coolers with
ice packs for easy transport.
Self-monitoring—Participants completed a 3 d food record for the second study visit and
a daily food checklist for all subsequent visits. The daily food checklist imposed less
participant burden than food records, while still contributing to dietary adherence through
daily self-monitoring of consumption of key study foods, such as fish, flaxseed and oils.
Each week, the subjects rated their adherence to the diet for the week on a scale of 1
(‘excellent’) to 5 (‘poor’). This subjective score allowed the participant to reflect on and
report difficulties in following the diet and helped the dietitian address individual challenges
to dietary adherence.
Web-based diet education materials—The following intervention-specific education
materials were available to the participants through a password-protected website developed
by the Nutrition Applications for Health Communications and Interventions Core of the
UNC School of Public Health Nutrition Obesity Research Center: (1) Diet Guidelines; (2)
Food Lists; (3) Seven-day Meal Plan; (4) Reading Food Labels Guide; (5) Grocery
Shopping Guides; and (6) Dining Out Guide. In addition, more than fifty recipes using
study-provided foods and/or meeting study guidelines were included on the intervention
website.
The diet guidelines informed participants of specific dietary changes required. The food list
complemented the diet guidelines by categorising more than 270 foods into ‘allowed’,
‘limit’ and ‘avoid’ for easy reference. The 7 d meal plans provided practical guidance to
achieve the nutrient targets and were assigned to each participant according to their baseline
BMI and calculated for weight maintenance (example meal plan in Supplementary
Appendix 2, available online).
‘Reading food labels’ is an activity booklet that illustrated how to identify high-LA foods by
reading food ingredients lists. Grocery shopping guides, which list low-LA brand-name
foods in all major food categories at ten local grocery stores, assisted participants in
obtaining low-LA foods for meals prepared at home. The dining out guide assisted in
identification of low-LA foods at local restaurants.
Assessment of diet adherence
Multiple 24 h dietary recall assessment—The UNC Nutrition and Obesity Research
Center Diet, Physical Activity and Body Composition in Human Populations Core (NORC)
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collected participant dietary intake data using six unannounced telephone-administered 24 h
recalls per subject: three were administered prior to the intervention (two weekdays, one
weekend day) and three were administered in the final 6 weeks of the 12-week intervention
(two weekdays, one weekend day). Nutrient values were estimated using the Nutritional
Data System for Research (NDSR) software version 2009–2010, developed by the Nutrition
Coordinating Center, University of Minnesota, Minneapolis, MN(23). Because the study-
provided foods contained markedly different LA, ALA, AA, EPA and DHA contents than
commonly available US foods, the fatty acid contents of study-provided foods were
reconciled with the NDSR database in order to improve accuracy of the diet recalls. This
required creation of custom user-recipe projects matched to one-tenth of the analysed, study-
provided foods. An effort was also made to reconcile the fatty acid content of many of the
foods consumed outside the home by calling local eateries. Despite these efforts, the LA
content of some of the low-LA foods recommended for grocery shopping and dining out
were not able to be reconciled with the NDSR database.
Erythrocyte fatty acid analysis—Erythrocytes were obtained from the EDTA blood
samples after the plasma and buffy coat were removed. Following Bligh/Dyer extraction(23),
erythrocyte aliquots were heated at 100°C for 1 h with methanol containing 14 % boron
trifluoride to generate fatty acid methyl esters. These were then extracted into hexane and
analysed with a flame ionisation detector gas chromatograph (Agilent 6890 Plus LAN;
Agilent Technologies) equipped with a 30-m DBFFAP (nitroterephthalic acid modified
polyethylene glycol) capillary column. Fatty acids were identified through comparison with
a standard fatty acid methyl ester mixture (GLC-462). Values are expressed as percentages
of total erythrocyte fatty acids.
Data analysis
Because of the small sample size and non-normal distributions of dietary intake variables
and erythrocyte fatty acids, non-parametric analyses were performed. Median values and
inter-quartile ranges (IQR) for targeted fatty acids were calculated for both groups. Pre-to-
intra-intervention and between-group comparisons were made with the Wilcoxon signed-
rank test for matched pairs and the Wilcoxon rank-sum test, respectively. P values <0·05
were considered significant.
Results
A total of sixty-seven subjects were randomised to either the H3-L6 diet (n 33) or the L6
diet (n 34) (Table 2). Of these, eleven participants dropped out of the intervention after
randomisation (four in the H3-L6 diet group, seven in the L6 diet group) due to trauma
unrelated to diet (n 1), personal conflicts (n 2), disqualification after randomisation
(pregnancy or diabetes diagnosis) (n 3) or dislike of the assigned diet (n 5). One subject who
completed all other aspects of the study could not be reached by telephone to complete the
intra-intervention 24 h recall assessment. The non-completers (n 11) and completers with
pre- and intra-intervention diet data (n 55) had no significant differences in baseline intakes
of any target nutrients (P>0·05; Table 3).
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Median nutrient intakes and IQR for the fifty-five participants with the pre- and intra-
intervention 24-h recall data (n 28 for L6 diet, n 27 for H3-L6 diet) are presented in Table 3.
There were no significant pre-to-post intervention changes in the consumption of total fat,
carbohydrate, protein or total energy in either diet group. For the L6 group, dietary LA
declined from 7·4 en% (IQR 5·7–9·6) to 2·4 en% (IQR 2·0–2·9). The between-subject
variability of dietary LA intake by diet group is illustrated in Fig. 1. Total PUFA declined
from 8·1 en% (IQR 6·4–10·6) to 3·5 en% (IQR 3·1–4·3) and SFA increased from 10·5 en%
(IQR 9·1–11·9) to 14·0 en% (IQR 12·1–17·2). Intakes of n-3 PUFA did not change for the
L6 group. For the H3-L6 diet group, LA declined from 6·4 en% (IQR 5·3–7·4) to 2·5 en%
(IQR 2·2–3·9). ALA increased from 0·6 en% (IQR 0·5–0·9) to 1·6 en% (IQR 1·3–2·0). Daily
EPA + DHA consumption increased from 47 mg (IQR 20–71) to 1482 mg (IQR 374–2558).
Median erythrocyte fatty acids and IQR for the fifty-two participants with pre- and post-
intervention data (n 27 for L6 diet, n 25 for H3-L6 diet) are presented in Table 4. For the L6
group, erythrocyte LA declined (−13·6 %, P<0·01), and EPA (+51·3 %, P<0·01), DHA
(+18·8 %, P<0·01) and total SFA (+3·0 %, P=0·04) increased. For the H3-L6 diet group, LA
(−12·6 %, P<0·01) and AA (−14·1 %, P<0·01) declined, and EPA (+274 %, P<0·01) and
DHA (+80 %, P<0·01) increased. Substantial within-group variability in EPA and DHA
intakes were noted (Fig. 2).
Discussion
Here, we showed that dietary LA can be markedly reduced, with or without a concurrent
increase in n-3 PUFA, in a free-living adult population using an integrated diet method. To
our knowledge, this is the first demonstration that dietary n-6 LA can be lowered to amounts
consistent with historical US(2) or evolutionary diets(3) in an outpatient setting.
Dietary n-6 PUFA lowering for 12-weeks reduced the LA content and increased the EPA
and DHA content of the erythrocytes, without significantly altering the proportions of n-6
AA. Although it is often speculated that high n-6 LA intakes induce inflammation by
increasing the synthesis and subsequent metabolism of AA into inflammatory
derivatives(9,24), there are currently no human data supporting the proposition that dietary
LA substantially alters the abundance or metabolism of AA in human subjects(25). The
present finding that concurrent dietary lowering of both n-6 LA and AA did not significantly
reduce the AA content of erythrocytes is consistent with the idea that dietary LA has little or
no effect on tissue AA content. Importantly, however, the 12-week duration of dietary LA-
lowering employed here may not have been sufficient to achieve the steady-state
concentrations of erythrocyte AA due to the high LA content of the adipose tissue; LA
presently accounts for about 15 % of total fatty acids in the adipose tissue of the US
population(26), compared with only 6 % in 1961(27,28). Because the adipose tissue PUFA
have a slow rate of turnover(29,30) and mobilisation of LA from adipose tissue may attenuate
changes in circulating PUFA, dietary LA lowering may need to be maintained for relatively
long periods of time to elicit maximal changes in the AA content of the erythrocytes and
other circulating lipid pools.
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Dietary n-6 PUFA lowering for 12 weeks did produce significant increases in the EPA (+51
%) and DHA (+19 %) content of the erythrocytes, suggesting that high-LA diets may
interfere with the synthesis and/or accumulation of EPA and DHA in human tissues. Dietary
LA (18 : 2n-6) may reduce EPA and DHA in human tissues by: (1) impairing enzymatic
conversion of n-3 ALA (18 : 3n-3) to 18 : 4n-3 (the precursor to EPA)(31); (2) impairing
conversion of 24 : 5n-3 to 24 : 6n-3(32) (the precursor to DHA)(33); and (3) competing with
n-3 EPA and DHA (and n-6 AA) for esterification into the sn-2 position of
phospholipids(34). It is generally believed that the synthesis of DHA from dietary ALA is not
sufficient to maintain adequate DHA in human subjects(35). The present finding of increased
EPA and DHA accumulation with dietary n-6 lowering indicates that the DHA adequacy of
human tissues may depend on background n-6 PUFA consumption. Importantly, however,
erythrocyte fatty acid data cannot inform whether observed increases in EPA and DHA are
due to increased elongation/desaturation of n-3 ALA, reduced competition with n-6 LA (and
n-6 AA) for esterification or a combination of both. Tracer studies comparing the kinetics of
n-3 ALA elongation/desaturation in high- and low-LA diets are warranted.
The H3-L6 diet produced marked increases in erythrocyte n-3 EPA and DHA and a
reduction in n-6 AA, compared with the L6 diet; these changes were probably attributable to
consumption of preformed EPA and DHA from the seafood. The observed reduction in
erythrocyte AA may be due to increased competition with n-3 EPA and DHA for
esterification into the phospholipid sn-2 position, reduced elongation/ desaturation of n-6
LA or a combination of both.
Although the H3-L6 group achieved the median EPA + DHA intake target of ≥1000 mg/d
(Fig. 1), there was considerable within-group variability that was probably attributable to
aversion to fish in a subset of the participants. H3-L6 dieters who were unwilling to
consume at least one serving of seafood per d were encouraged to consume high-EPA +
DHA fish ‘as often as possible’ and to continue all other aspects of the intervention. The use
of only seafood, rather than n-3 supplements, to deliver EPA + DHA is a unique aspect of
the present study. Some of the EPA and DHA present in seafood are incorporated in
multiple phospholipid classes (e.g. phosphatidylethanolamine, phosphatidylcholine and
plasmalogens), which may have different absorption properties and biological activities than
the TAG and ethyl ester forms present in refined fish oils and medications(36,37). Seafood
also contains vitamins, minerals and other nutrients that affect the bioactivities of
accompanying fatty acids(38). However, future feeding trials may benefit by providing n-3
supplements to participants unwilling or unable to eat seafood on a daily basis in order to
provide more uniform amounts of EPA + DHA.
Limitations
Limitations of 24 h recalls for assessing nutrient intakes include the dependence on self-
reported data and under-reporting(39,40). However, multiple 24 h recalls have been validated
with doubly labelled water and are more highly correlated with present energy intake than
FFQ and diet history questionnaires(2,41 – 46). The 24 h diet recall method is considered a
valid tool for estimating dietary intake and is frequently used to validate new methods of
diet assessment(47,48). In addition, this method allowed us to update the nutrient database for
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the specific study foods and recipes for a more accurate reflection of study food intake
during the diet intervention. The NDSR contains detailed fatty acid data, and our efforts to
reconcile the fatty acid contents of study-provided foods with the NDSR database probably
improved the accuracy of the diet recalls.
Some of the low-LA foods recommended for purchase were not able to be reconciled with
the NDSR database and, therefore, our 24 h recall data may overestimate LA intakes during
the intervention in both diet groups. Because fatty acid values from direct laboratory testing
were reconciled with the NDSR database for all study-provided animal foods, and these
study foods had fewer zero values for AA, EPA and DHA than corresponding foods in the
NDSR database used in the pre-intervention phase, apparent increases in AA, EPA and
DHA may have been overestimated. The observed reduction in erythrocyte LA in both
groups and marked increase in erythrocyte EPA and DHA in the H3-L6 group provide
further evidence of adherence to the study interventions, but cannot quantify whether the
nutrient intake targets were achieved. Finally, because this population with chronic
headaches may have been more adherent to the study diets due to the potential for pain
relief, the magnitudes of the observed dietary changes are not necessarily generalisable to
non-pain populations.
Conclusion
Dietary LA can be lowered to ≤2·5 en%, with or without concurrent increases in dietary n-3
PUFA, in an outpatient clinical trial setting using this integrated diet method. These diet
methods are intended to serve as a template for future human trials in other clinical
populations to evaluate the effects of lowering dietary LA.
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Dietary linoleic acid (LA) in the pre-intervention (Pre) and intra-intervention (Intra) periods.
L6, low-n-6 diet; H3-L6, high-n-3 low-n-6 diet; en%, percentage of food energy. —, Median
dietary LA intake.
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Dietary EPA+ DHA in the pre-intervention (Pre) and intra-intervention (Intra) periods. L6,
low- n-6 diet; H3-L6, high- n-3 low- n-6 diet. –, Median dietary EPA+DHA intake.
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